Form 4 holding
Director
Theravance Biopharma, Inc.
- Security class
- Ordinary Shares
- Shares / value
- 78,010
- Estimated value
- $802,723
- Report date
- 26 Apr 2022
- Price
- $10.29
- Ownership
- Direct
William D. Young - Director at Theravance Biopharma, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- TBPH on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by William D. Young since 18 Aug 2025
Reported holdings for William D. Young in Theravance Biopharma, Inc.
Form 4 holding
Director
Theravance Biopharma, Inc.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 28,000
- Estimated value
- Report date
- 26 Apr 2022
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for William D. Young in Theravance Biopharma, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.